Medicine and Dentistry
Therapeutic Procedure
100%
Melanoma
76%
Patient
59%
Antibody-Drug Conjugate
59%
Triple Negative Breast Cancer
57%
Neoplasm
46%
Cyclin-Dependent Kinase
38%
Breast Cancer
38%
Immunity
27%
Prognosis
26%
Mechanism of Action
25%
Gene
25%
Immune Checkpoint Inhibitor
25%
Cancer Therapy
21%
Therapeutics
19%
Folate Receptor 1
19%
Antifolate
19%
Protein
19%
Proteochondroitin Sulfate
19%
Cytotoxic T-Cell
19%
Antibody Therapy
19%
Cancer Model
19%
DNA
19%
Epidermal Growth Factor Receptor
19%
Cancer Growth
19%
Cancer Cell
18%
Monotherapy
17%
Clinical Management
13%
Immune Response
12%
In Vitro
11%
Tumor Xenograft
8%
Xenograft
7%
Toxicity
7%
Tumor Regression
6%
Immunoglobulin G1
6%
Hematological Cancer
6%
Vascularity
6%
T Cell
6%
Programmed Death 1 Receptor
6%
Cancer
6%
Non-Hodgkin Lymphoma
6%
Experience
6%
Immune-Related Adverse Events
6%
Immunocompetent Cell
6%
Tumor Progression
5%
Cells
5%
Cyclin Dependent Kinase Inhibitor
5%
Targeted Therapy
5%
Immunology and Microbiology
Immunoglobulin E
38%
Programmed Death-Ligand 1
28%
Xenograft
27%
Antigen
19%
B Cell
19%
Monocyte
12%
Macrophage
12%
Lung
9%
Antibody-Dependent Cell-Mediated Cytotoxicity
6%
Basophil Granulocyte
6%
Effector Cell
6%